Dextech Medical AB est une société de recherche basée en Suède et spécialisée dans l'oncologie urologique. Elle se concentre sur le cancer de la prostate,

DexTech Medical fick i början av mars klartecken från läkemedelsverket att påbörja sin fas II-studie med läkemedelskandidaten OsteoDex mot

DexTech Medical AB, Delårsrapport 1 juli - 30 september 2019 tor, okt 24, 2019 12:40 CET. Med ”Bolaget” eller ”DexTech” avses DexTech Medical AB med organisationsnummer 556664-6203. Sammanfattning av första kvartalet (juli - september 2019) Nettoomsättningen uppgick till 0,0 (0,0) MSEK Rörelseresultatet uppgick till -2,0 (-1,9) MSEK DexTech Medical AB (”DexTech”) är ett svenskt forskningsbolag specialiserat på urologisk onkologi, främst prostatacancer. Utifrån en egenutvecklad patenterad teknologiplattform har bolaget utvecklat fyra läkemedelskandidater med patent/patentansökningar på flera nyckelmarknader. DexTech genomför nu en företrädesemission om cirka DexTech Medical informerar om licensarbetet och bolagets kapitalbehov tis, apr 23, 2019 16:48 CET. Bolaget har sammanställt ett s.k. virtuellt datarum innehållande all information om OsteoDex, DexTechs läkemedelskandidat för behandling av skelettmetastaser vid avancerad prostatacancer (mCRPC) samt övriga projekt och formell bolagsinformation.

Dextech medical

These shocking statistics highlight the issues around poor treatment and how it can affect bot If it feels like doctors speak a different language, you're not far from the truth. Although medical terms are confusing, you can find definitions in many ways so you know what your doctor is talking about. Use the internet for information, Medical assistants are a vital part of the healthcare sector. They provide an invaluable service and assist in the daily running of any medical facility. If you’re looking for a rewarding career and enjoy helping people, then a medical assi Advanced age comes with many special privileges, such as seeing grandkids grow up, and spending great times with family. However, age also comes with unique challenges. Frailty and health scares can be some of the challenges that require vi One of the biggest reasons senior citizens end up in the hospital is because of a fall in the home.

Bolaget har 1 anställda, snittlönen har minskat 1,63%. Den 13 oktober 2016 avslutades teckningstiden i DexTech Medical AB:s ("DexTech") företrädesemission om högst cirka 15,3 MSEK, i vilken även allmänheten gavs möjlighet att teckna aktier.

På måndagen meddelade DexTech Medical att man avslutat rekryteringen till sin fas IIb-studie med läkemedelskandidaten OsteoDex för behandling av

DexTech Medical AB är ett svenskt forskningsföretag som utifrån sin teknikplattform har utvecklat fyra läkemedelskandidater som skyddas av patent. Huvudkandidaten är OsteoDex för behandling av kastrationsresistent prostatacancer (CRPC) med skelettmetastaser.

DexTech Medical AB is a Swedish research company that, based on its technology platform, has developed four drug candidates that are protected by patents. The main candidate is OsteoDex for the treatment of castration-resistant prostate cancer (CRPC) with skeletal metastases.

För att kartlägga möjliga Dextech Medical AB develops drug candidates for application in urological oncology primarily for prostate cancer. Its principal product candidate is OsteoDex that has completed phase IIb clinical trial for DexTech Medical is in a falling trend channel in t This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. It can be a long snippet, a short snippet, whatever you prefer the size of card and description to be.This is the body text of the blog post to give visitors an idea of what the post is about beyond just the title. DexTech Medical. 51,60.

Some offer international transportation services.
Rapporter börsen

When a medical procedure goes wrong, life can quickly become difficult in so many different ways. Dealing with all the red tape at insurance companies and doctor’s offices can complicate matters and add to the confusion. When you believe a Statistics from the Journal of the American Medical Association state that medical negligence is the third leading cause of death in the country.

DexTech Medical AB is a Swedish research company that, based on its technology platform, has developed four drug candidates that are protected by patents. The main candidate is OsteoDex for the treatment of castration-resistant prostate cancer (CRPC) with skeletal metastases.

2019-06-27 DexTech Medical är ett forskningsbolag. Idag innehas specialisering främst inom urologisk onkologi, där vanliga sjukdomar inkluderar prostatacancer. En stor del av forskningen utförs i samarbete med övriga internationella aktörer, forskningsinstitut och universitet. Bolaget etablerades under 2004 och har sitt huvudkontor i Uppsala. Artiklar, analyser, telegram, pressreleaser och analytikernas aktieråd rörande DexTech Medical Informationen är fördröjd med 15 minuter och levereras av Millistream. Senaste analyserna DexTech Medical AB Dextech Medical AB engages in the research and development of drug candidates for urological oncology.

DexTech Medical AB (”DexTech”) är ett svenskt forskningsbolag specialiserat på urologisk onkologi, främst prostatacancer. Utifrån en egenutvecklad patenterad teknologiplattform har bolaget utvecklat fyra läkemedelskandidater med patent/patentansökningar på flera nyckelmarknader. DexTech genomför nu en företrädesemission om cirka

Zometa is the market leader bisphosphonate medication for treatment of osteoporosis and the prevention and delay of fractures caused by skeletal metastasis. DexTech Medical AB researches and develops drug candidates for the treatment of bladder and prostate cancer. The Company offers its products to the pharmaceutical and medical industries around the DexTech is a Swedish research company specializing in urological oncology, mainly prostate cancer. DexTech develops drug candidates based on a modified carbohydrate molecule in combination with active substances, including generics. The company has a strong clinical foundation with valuable specialist expertise from research laboratory and View the latest DexTech Medical AB (DEX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Business Description DexTech Medical AB develops candidate medications with applications within urological oncology, primarily for prostate cancer. Its medication candidates include GuaDex, DexTech is a Swedish research company specializing in urological oncology, mainly prostate cancer.

P.g.a. rådande pandemi kommer det att bli gles sittning med behörigt avstånd mellan de närvarande. DexTech Medical är ett forskningsbolag.